The DOI matches its Crossref record; 105 of the 108 references it cites were found in a registry or an index, and 2 are not checked yet; none of the 111 sources its claims cite is checked for support yet.
Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
Open accessAbstract
The multistep process of in vivo reprogramming, mediated by the transcription factors (TFs) Oct4, Sox2, Klf4, and c-Myc (OSKM), holds great promise for the development of rejuvenating and regenerative strategies. However, most of the approaches developed so far are accompanied by a persistent risk of tumorigenicity. Here, we review the groundbreaking effects of in vivo reprogramming with a particular focus on rejuvenation and regeneration. We discuss how the activity of pioneer TFs generates cellular plasticity that may be critical for inducing not only reprogramming and regeneration, but also cancer initiation. Finally, we highlight how a better understanding of the uncoupled control of cellular identity, plasticity, and aging during reprogramming might pave the way to the development of rejuvenating/regenerating strategies in a nontumorigenic manner.
Checked 2026-11-10 · 2 references not checked yet
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that OSKM-mediated in vivo reprogramming can rejuvenate and improve regeneration but carries a persistent tumorigenic risk, with pioneer transcription factors generating cellular plasticity that underlies both beneficial and malignant outcomes. It proposes that uncoupling cellular identity, plasticity, and aging could enable nontumorigenic reprogramming-based strategies.
Key findings
- Partial/cyclic OSKM can reverse aging features: OSKMLN in aged (60–90 years) versus young (25–35 years) fibroblasts/endothelial cells induced rapid, persistent amelioration of aging hallmarks and reversal of cellular age; cyclic OSKM (2 days per week) erased epigenetic signs of aging and improved aging hallmarks, though age reduction was constrained to kidney and skin.
- OSKM effects are dose-, duration-, and cell-type-dependent: short OSKM exposure (6–12 days) in adult cardiomyocytes reprogrammed them toward a fetal state and improved heart repair; 6 days caused moderate reversible cardiac remodeling, while 21 days triggered epithelial-like neoplasms, and one OSKM allele led to cardiac neoplasms after 7 weeks. Low OSKM expression led to teratomas, whereas high OSKM triggered malignant tumors.
- Tumorigenic risk accompanies in vivo reprogramming: full reprogramming forms teratomas, and premature termination after ~7 days of OSKM produced malignant tumors in various organs, whereas dysplasia after short exposure (~2 days) was often reversed. Excluding c-Myc avoided cancerous eye lesions after prolonged expression.
- Pioneer TFs generate cellular plasticity through promiscuous chromatin binding: Myod1 binds neuronal genes and Ascl1 binds myogenic genes; Atoh8 controls cellular plasticity; early intermediates can be highly prone to iPSC generation without significant loss of MEF identity, and rejuvenation may occur before identity changes in some settings.
Methods
- Review article; no primary experimental design, sample, or statistical analysis is reported. It synthesizes published studies on in vivo OSKM reprogramming, partial reprogramming, rejuvenation/regeneration, tumorigenesis, and pioneer TF activity.
- Main analysis is a narrative synthesis, supported by conceptual figures and a table of pioneer TF functions across development, regeneration, and tumorigenesis.
Limitations
- Stated: in vivo reprogramming studies are not numerous and most findings still rely on in vitro work; the molecular bases of cell type- and organ-specific sensitivity remain imperfectly understood; results are difficult to compare because the reprogramming cocktail and duration of exposure often differ.
- Stated: functional and physiological effects of rejuvenation need systematic assessment; partial restoration of youthful gene expression is limited and may not correlate with functional reversion; lineage-tracing tools and more human-cell studies are needed.
- Evident: as a review, it does not provide new experimental data, and several mechanistic claims are synthesized from referenced studies rather than directly tested here.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 111 cited sources checked · 0 supported · 0 flagged
- Premisecitation§ Pluripotent reprogramming is a stepwise process
Oct4, Sox2, and Klf4 belong to the family of pioneer transcription factors, able to interact with and remodel the nucleosome to open silent chromatin.
“Oct4, Sox2, and Klf4 belong to the family of 'pioneer' TFs, a specific class of molecules able to interact with, and remodel, the nucleosome to open silent chromatin [16].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Comparison of the roadmaps of reprogramming and transformation at the single cell level in mouse embryonic fibroblasts demonstrated the existence of an early shared epigenetic program induced by OSKM and oncogenic K-Ras/c-Myc.
“Comparison of the roadmaps of reprogramming and transformation at the single cell level in mouse embryonic fibroblasts (MEFs) demonstrated the existence of an early shared epigenetic program induced by OSKM and oncogenic K-Ras/c-Myc (Figure 1) [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Partial reprogramming in myofibers promoted tissue regeneration in a chemically induced tibialis anterior muscle degeneration model.
“Similarly, partial reprogramming in myofibers promoted tissue regeneration in a chemically induced tibialis anterior muscle degeneration model.”
Quote in the paperNot a substantial claim - Premisecitation§ Pluripotent reprogramming is a stepwise process
Partial reprogramming approaches restored vision.
“These approaches led to groundbreaking effects both in vitro and in vivo, including rejuvenation [8][9][10][11], improvement of regenerative abilities in various organs [9,12,13], and restoration of vision [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Many epigenetic marks remodeled during early reprogramming are also dysregulated during aging, including post-translational DNA methylation, histone modifications, and chromatin remodeling.
“Many of the epigenetic marks that are remodeled during early reprogramming are also dysregulated during the aging process, including post-translational DNA methylation, modifications of histones, and chromatin remodeling [23].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pluripotent reprogramming is a stepwise process
Partial reprogramming approaches led to rejuvenation in vitro and in vivo.
“These approaches led to groundbreaking effects both in vitro and in vivo, including rejuvenation [8][9][10][11], improvement of regenerative abilities in various organs [9,12,13], and restoration of vision [14].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Comparison of gene signatures of OSKM-mediated reprogramming and K-Ras-driven transformation in the pancreas revealed some shared transcriptomic features.
“A recent comparison of gene signatures of OSKM-mediated reprogramming and K-Ras-driven transformation in the pancreas revealed some shared transcriptomic features [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
A single short OSKM pulse performed early in life modestly prevented some age-related tissue structure deteriorations and fibrosis.
“Finally, a single short OSKM pulse performed early in life was reported to modestly prevent some age-related tissue structure deteriorations and fibrosis [29].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Reprogramming in vivo triggers rejuvenation and improves regeneration
A recent analysis of pancreatic cells at day 7 of reprogramming in vivo showed that cellular intermediates, prone or refractory to reprogramming, also emerge in vivo.
“A recent analysis of pancreatic cells at day 7 of reprogramming in vivo showed that cellular intermediates, prone or refractory to reprogramming, also emerge in vivo [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pluripotent reprogramming is a stepwise process
Partial reprogramming was reported to trigger and/or foster oncogenic transformation in certain normal and neoplastic contexts.
“However, partial reprogramming was reported to trigger and/or foster oncogenic transformation in certain normal and neoplastic contexts [3,4,15].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Specific and short expression of OSKM for 6-12 days in adult cardiomyocytes reprogrammed them toward a fetal state.
“A specific and short expression of OSKM (6-12 days) in adult CMs reprogrammed them toward a fetal state [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pluripotent reprogramming is a stepwise process
Initial attempts at in vivo reprogramming showed that it triggers the formation of benign and malignant tumors.
“However, initial attempts at in vivo reprogramming showed that it triggers the formation of not only benign, but also malignant tumors [3,4].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pluripotent reprogramming is a stepwise process
Differentiated cell types can be reprogrammed to pluripotency in vivo.
“instrumental studies demonstrated that differentiated cell types can also be reprogrammed to pluripotency in vivo, paving the way to future applications in regenerative medicine [2,3].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Development of malignant tumors in various organs occurs when reprogramming is induced but prematurely abrogated before reaching pluripotency, after 7 days of OSKM expression.
“However, pioneer work reported the development of malignant tumors in various organs when reprogramming was induced but prematurely abrogated before reaching pluripotency (after 7 days of OSKM expression) [4,33].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Adeno-associated virus delivery of OSK significantly restored youthful features.
“In that context, the adeno-associated virus (AAV) delivery of OSK significantly restored youthful features [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pluripotent reprogramming is a stepwise process
Promiscuous binding of pioneer transcription factors to the genome was recently found to trigger undesired epigenetic and transcriptomic changes in certain contexts.
“Hence, the promiscuous binding of pioneer TFs to the genome was recently found to trigger undesired epigenetic and transcriptomic changes in certain contexts [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given§ Pluripotent reprogramming is a stepwise process
During reprogramming, cells reach a point of no return after which they will not go back to their differentiated state.
“During the process, the cells reach a 'point of no return' after which they will not go back to their differentiated state (Figure 1).”
Quote in the paperNot a substantial claim - Premisecitation§ Glossary
OSKM regulate genes critical for the stem cell microenvironment, leading to stem cell proliferation.
“Mechanistically, OSKM regulate genes critical for the stem cell microenvironment, leading to stem cell proliferation [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given§ Pluripotent reprogramming is a stepwise process
A large proportion of the epigenetic features remodeled during the early phase of reprogramming are also modified during regeneration and aging.
“A large proportion of the epigenetic features remodeled during the early phase of reprogramming are also modified during regeneration and aging.”
Quote in the paperNot a substantial claim - Interpretationnone given§ Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
Most approaches developed so far for in vivo reprogramming are accompanied by a persistent risk of tumorigenicity.
“However, most of the approaches developed so far are accompanied by a persistent risk of tumorigenicity.”
Quote in the paperNot a substantial claim - Interpretationnone given§ Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
The activity of pioneer transcription factors generates cellular plasticity that may be critical for inducing reprogramming, regeneration, and cancer initiation.
“We discuss how the activity of pioneer TFs generates cellular plasticity that may be critical for inducing not only reprogramming and regeneration, but also cancer initiation.”
Quote in the paperNot a substantial claim - Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Pluripotent reprogramming and oncogenic transformation share molecular analogies.
“Pluripotent reprogramming and oncogenic transformation share molecular analogies, as reviewed elsewhere [7,31,32].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [7]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [32]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Prolonged exposure to OSKM of about 7 days drives subsequent formation of tumors, which persist after OSKM removal.
“However, prolonged exposure (~7 days) drives the subsequent formation of tumors, which persist after OSKM removal [4].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
OSKM expression before or during myocardial infarction improved heart repair through proliferation of pre-existing cardiomyocytes.
“Moreover, OSKM expression, before or during myocardial infarction, improved heart repair through proliferation of pre-existing CMs.”
Quote in the paperNot a substantial claim - Premisecitation§ Pluripotent reprogramming is a stepwise process
Partial reprogramming approaches improved regenerative abilities in various organs.
“These approaches led to groundbreaking effects both in vitro and in vivo, including rejuvenation [8][9][10][11], improvement of regenerative abilities in various organs [9,12,13], and restoration of vision [14].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [13]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Reprogramming mediated by OSKMLN induces rapid and persistent amelioration of aging hallmarks and reversal of cellular age at transcriptomic, epigenetic, and cellular levels in aged compared with young fibroblasts and endothelial cells.
“Recent studies demonstrated that reprogramming (mediated by OSKM+Lin28+Nanog: OSKMLN) induces a rapid and persistent amelioration of aging hallmarks and a reversal of cellular age at the transcriptomic, epigenetic, and cellular levels in aged (60-90 years) compared with young (25-35 years) fibroblasts/endothelial cells [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pluripotent reprogramming is a stepwise process
The inability of cells to successfully overcome obstacles including activation of oncogenic barriers such as senescence and cell death partly explains the low efficiency of reprogramming.
“The inability of cells to successfully overcome different obstacles, including the activation of oncogenic barriers (senescence and cell death), partly explains the low efficiency of the process [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Loss of epigenetic information can cause mammalian aging.
“Moreover, recent work showed that loss of epigenetic information can cause mammalian aging [23].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
Natural killer cells constrain in vivo reprogramming by targeting reprogramming cells that upregulate NK-activating ligands MULT1, ICAM1, and CD155, which bind the NKG2D receptor.
“By contrast, natural killer (NK) cells constrain the process by targeting reprogramming cells that upregulate NK-activating ligands (MULT1, ICAM1, and CD155) that bind the NKG2D receptor [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Glossary
The refractory cluster harbors high activity of the AP-1 family of transcription factors, in line with the barrier role of these factors in vitro.
“The refractory cluster harbors high activity of the AP-1 family of TFs, in line with the barrier role of these factors in vitro [6,[18][19][20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6,[18][19][20]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Reprogramming generates cellular plasticity
These trophectoderm-like cells were successfully stabilized into induced trophectodermal stem cells that resembled both molecularly and functionally trophectodermal stem cells derived from first-trimester placentas.
“These cells were successfully stabilized into induced trophectodermal stem cells (TSCs) that resembled both molecularly and functionally TSCs derived from first-trimester placentas.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Pioneer TF activity during reprogramming and transdifferentiation
The phenomenon of pioneer transcription factor-generated plasticity depends on the epigenome of the cell of origin, the cofactors, and the intrinsic abilities of the transcription factor.
“However, this phenomenon depends on the epigenome of the cell of origin, the cofactors, and the intrinsic abilities of the TF.”
Quote in the paperSubstantial claim - Premisecitation§ Trends in Cell Biology
OSKM-based reprogramming to generate iPSC-derived neurons is limited for modeling aging because the neurons are reset and have erased many aging features required for AAD modeling.
“However, such an approach is limited to model aging because the iPSC-derived neurons are reset and have erased many of the aging features required for AAD modeling [59].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
Numerous embryonic pioneer transcription factors are able to drive conversion of fibroblasts toward a plethora of lineages.
“Numerous embryonic pioneer TFs are able to drive the conversion of fibroblasts toward a plethora of lineages [44].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Trends in Cell Biology
OSKM-based reprogramming methods have been used to generate patient-derived cell types of interest, such as neurons, for neurological age-associated diseases.
“different laboratories have used OSKM-based reprogramming methods to generate patient-derived cell types of interest, such as neurons [58].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
The ability of pioneer transcription factors to initiate transcriptional programs is instrumental for programming cell fate during development.
“The ability of pioneer TFs to initiate transcriptional programs is instrumental for programming cell fate during development [43].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given§ Pioneer TF activity in regeneration and cancer initiation
During both repair and tumorigenesis, stress-responsive enhancers become activated and override the homeostatic enhancer landscape.
“Molecularly, during both repair and tumorigenesis, 'stress-responsive' enhancers become activated and override the homeostatic enhancer landscape.”
Quote in the paperSubstantial claim - Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
OSK hijack mouse embryonic fibroblast cofactors Runx1, Cebpa, Cebpb, and Fra1 and epigenetic regulators Brg1, Hdac1, and Mbd3 to initiate inactivation of mouse embryonic fibroblast enhancers.
“OSK also hijack MEF cofactors (Runx1, Cebpa, Cebpb, and Fra1) and epigenetic regulators (Brg1, Hdac1, and Mbd3) to initiate the inactivation of MEF enhancers [18,46].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [46]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity in regeneration and cancer initiation
Sox9 and Klf4 trigger lineage infidelity by conferring a mixed progenitor/ductal identity by repressing some acinar enhancers and activating ductal ones.
“The two TFs trigger lineage infidelity by conferring a mixed progenitor/ductal identity by repressing some acinar enhancers and by activating ductal ones [49].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity in regeneration and cancer initiation
K-Ras G12D triggers emergence of a mixed cellular state from alveolar type 2 cells during the early phase of lung tumorigenesis.
“K-Ras G12D also triggers the emergence of a mixed cellular state from AT2 cells during the early phase of lung tumorigenesis [53].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Uncoupling cellular identity, plasticity, and aging during reprogramming
Cell fate conversion does not scale gradually with increasing expression level of reprogramming factors but rather depends on a critical expression threshold.
“Another conclusion is that cell fate conversion does not scale gradually with increasing the expression level of reprogramming factors but rather depends on a critical expression threshold.”
Quote in the paperSubstantial claim - Premisecitation§ Pioneer TF activity in regeneration and cancer initiation
In the lung, regeneration triggers lineage infidelity in alveolar type 2 epithelial cells, which acquire a pre-alveolar type-1 mixed cell identity.
“Similarly in the lung, regeneration triggers lineage infidelity in alveolar type 2 epithelial cells, which acquire a pre-alveolar type-1 mixed cell identity [52].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Trends in Cell Biology
When partial reprogramming is induced in primary adipogenic and mesenchymal stem cells, somatic identity was found to be suppressed transiently.
“By contrast, when partial reprogramming is induced in primary adipogenic and mesenchymal stem cells, the somatic identity was found to be suppressed transiently [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
Transcription-factor-mediated cell fate conversions require a genome-wide epigenetic resetting that includes opening of silent chromatin.
“TF-mediated cell fate conversions require a genome-wide epigenetic resetting that includes the opening of silent chromatin.”
Quote in the paperSubstantial claim - Premisenone given§ A tumorigenic risk is associated with in vivo reprogramming
Some kidney tumors share characteristics with Wilms' tumors, the most common pediatric kidney tumor.
“Some kidney tumors share characteristics with Wilms' tumors, the most common pediatric kidney tumor.”
Quote in the paperNot a substantial claim - Premisecitation§ Reprogramming generates cellular plasticity
The first bifurcation leads cells to assume a refractory stromal fate or a prone mesenchymal-epithelial transition fate that mainly gives rise to reprogrammed cells.
“The first bifurcation leads cells to assume a 'refractory' stromal fate or a 'prone' mesenchymalepithelial transition (MET) fate that mainly gives rise to reprogrammed cells.”
Quote in the paperSubstantial claim - Premisecitation§ Reprogramming generates cellular plasticity
In vitro reprogramming is executed in a series of bifurcating decisions, where each point on the reconstructed trajectories corresponds to a concrete cellular decision.
“In line with this, recent insights from single cell approaches showed that in vitro reprogramming is executed in a series of bifurcating decisions, where each point on the reconstructed trajectories corresponds to a concrete cellular decision [35,36].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given§ A tumorigenic risk is associated with in vivo reprogramming
Mice carrying only one OSKM allele developed cardiac neoplasms after 7 weeks of OSKM exposure.
“Interestingly, mice carrying only one OSKM allele developed cardiac neoplasms after 7 weeks of OSKM exposure.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Pioneer TF activity in regeneration and cancer initiation
The ability of pioneer transcription factors to sense stress and trigger lineage infidelity in a regenerative context is hijacked during cancer initiation.
“The ability of pioneer TFs to sense stress and trigger lineage infidelity in a regenerative context is hijacked during cancer initiation.”
Quote in the paperSubstantial claim - Premisecitation§ Reprogramming generates cellular plasticity
Advancement of single cell technologies showed that aberrant gene inductions correspond to true cell fate decisions.
“The advancement of the single cell technologies showed instead that they correspond to true cell fate decisions.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Pioneer TF activity during reprogramming and transdifferentiation
Pioneer transcription factors have the ability to generate cellular plasticity especially via their promiscuous binding to chromatin.
“Altogether, these findings highlight the ability of pioneer TFs to generate cellular plasticity especially via their promiscuous binding to chromatin.”
Quote in the paperSubstantial claim - Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Exclusion of c-Myc from the cocktail was sufficient to avoid development of cancerous lesions in the eye after prolonged expression.
“For example, the exclusion of c-Myc from the cocktail was sufficient to avoid the development of cancerous lesions in the eye after prolonged expression [14].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
Myt1l exerts a pro-neuronal function by repressing a variety of non-neuronal genes occasionally induced by Ascl1.
“Myt1l exerts a pro-neuronal function by repressing a variety of non-neuronal genes occasionally induced by Ascl1 [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premiseown data§ Uncoupling cellular identity, plasticity, and aging during reprogramming
Multi-omics characterization of rare cells revealed existence of a partitioned regulatory network, driven by the bHLH transcription factor Atoh8, which controls specifically cellular plasticity.
“Multi-omics characterization of these rare cells revealed the existence of a partitioned regulatory network, driven by the bHLH TF Atoh8, which controls specifically cellular plasticity.”
Quote in the paperSubstantial claim - Premisecitation§ Uncoupling cellular identity, plasticity, and aging during reprogramming
Capture of early cellular intermediates allowed researchers to uncouple regulation of cellular identity and plasticity during mouse embryonic fibroblast reprogramming.
“In line with this, the capture of early cellular intermediates recently allowed researchers to uncouple the regulation of cellular identity and plasticity during MEF reprogramming [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Reprogramming generates cellular plasticity
Late bifurcations generate a battery of alternative cell fates, such as neural and extra-embryonic lineages, in both human and mouse cells.
“By contrast, late bifurcations were found to generate a battery of alternative cell fates, such as neural and extra-embryonic lineages in both human and mouse cells [35,36].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity in regeneration and cancer initiation
Under stress, pancreatic acinar cells induce expression of the pioneer transcription factors Sox9 and Klf4, which are normally expressed by ductal cells.
“Under stress, pancreatic acinar cells induce the expression of the pioneer TFs Sox9 and Klf4, which are normally expressed by ductal cells.”
Quote in the paperSubstantial claim - Premisecitation§ Trends in Cell Biology
Comparison of neurons derived from fibroblasts from patients with Alzheimer's disease using reprogramming or direct conversion revealed age-dependent features, such as a pronounced instability of the mature neuronal fate.
“Therefore, the comparison of neurons derived from fibroblasts from patients with Alzheimer's disease using reprogramming or direct conversion revealed age-dependent features, such as a pronounced instability of the mature neuronal fate [62].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Outstanding questions
Msx1 was found to restore a certain degree of youthful expression in myogenic cells.
“Recently, the multipotent factor Msx1 was found to restore a certain degree of youthful expression in myogenic cells [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Outstanding questions
Depending on the cellular model and the reprogramming protocol used, this window can lead to reversible dysplastic features in cells.
“However, depending on the cellular model and the reprogramming protocol used, this window can lead to reversible dysplastic features in cells[4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given§ Pioneer TF activity during reprogramming and transdifferentiation
The activity of pioneer transcription factors is dependent on different parameters, including stage-specific cofactors.
“Interestingly, their activity is dependent on different parameters, including stage-specific cofactors.”
Quote in the paperNot a substantial claim - Premisecitation§ Pioneer TF activity in regeneration and cancer initiation
In response to oncogenic K-Ras G12D, Sox9/Klf4-mediated acinar-to-ductal metaplasia is also induced before formation of pancreatic ductal adenocarcinoma.
“In response to oncogenic K-Ras (K-Ras G12D ), Sox9/Klf4-mediated ADM is also induced before the formation of pancreatic ductal adenocarcinoma [50,51].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity in regeneration and cancer initiation
This lineage infidelity process is reinforced by activation of specific stress-induced transcription factors, such as ETS2 by MAPK-mediated phosphorylation.
“This lineage infidelity process is reinforced by the activation of specific stress-induced TFs, such as ETS2 by MAPK-mediated phosphorylation [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ A tumorigenic risk is associated with in vivo reprogramming
Dosage and duration of OSKM exposure in adult cardiomyocytes influenced development of heart tumors.
“At the cellular level, the dosage and duration of OSKM exposure in adult CMs also influenced the development of heart tumors [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Outstanding questions
A shared molecular program emerges in cellular intermediates during reprogramming (induced by OSKM) and oncogenic transformation (induced by K-Ras G12D and c-Myc).
“A shared molecular program emerges in cellular intermediates during reprogramming (induced by Oct4, Sox2, Klf4, and c-Myc; OSKM) and oncogenic transformation (induced by an oncogenic form of K-Ras mutated on a single residue: K-Ras G12D and c-Myc)[6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning§ Pioneer TF activity during reprogramming and transdifferentiation
Promiscuous activity of pioneer transcription factors needs to be canalized in different ways, including by transcriptional repressors such as Myt1l.
“Therefore, this promiscuous activity needs to be canalized in different ways, including by transcriptional repressors, such as Myt1l.”
Quote in the paperSubstantial claim - Premisereasoning§ Pioneer TF activity in regeneration and cancer initiation
In examples of regeneration, lineage infidelity is transient and resolved rapidly.
“In these examples of regeneration, lineage infidelity is transient and resolved rapidly.”
Quote in the paperSubstantial claim - Premisecitation§ Reprogramming generates cellular plasticity
Emergence of a cluster of trophectoderm-like cells was recently reported during OSKM reprogramming of human dermal fibroblasts.
“The emergence of a cluster of 'trophectoderm-like' cells was recently reported during OSKM reprogramming of human dermal fibroblasts [41].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
Oct4, Sox2, and Klf4 are not distributed similarly on chromatin when expressed solely or in combination.
“In line with this, Oct4, Sox2, and Klf4 are not distributed similarly on the chromatin when expressed solely or in combination (Figure 2A) [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given§ Uncoupling cellular identity, plasticity, and aging during reprogramming
Recent work deciphered the sequence by which cellular identity, plasticity, and aging are modulated during reprogramming.
“Recent work deciphered the sequence by which cellular identity, plasticity, and aging are modulated during reprogramming.”
Quote in the paperSubstantial claim - Premisecitation§ Trends in Cell Biology
Direct conversion of fibroblasts into induced neurons maintains the age-associated features of donor cells.
“As an alternative, the so-called direct conversion of fibroblasts into induced neurons maintains the age-associated features of donor cells [60,61].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Uncoupling cellular identity, plasticity, and aging during reprogramming
Early intermediates are already highly prone to generate iPSCs even if their mouse embryonic fibroblast identity scores are not yet significantly decreased.
“These early intermediates are already highly prone to generate iPSCs even if their MEF identity scores are not yet significantly decreased [35,37].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning§ A tumorigenic risk is associated with in vivo reprogramming
OSKM exposure promotes neoplasia in certain settings.
“Altogether, these findings indicate that OSKM exposure promotes neoplasia in certain settings.”
Quote in the paperSubstantial claim - Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiation
When Myt1l expression is combined with Myod1, Myod1 unexpectedly promotes emergence of neurons by binding promiscuously to neural genes.
“Interestingly, however, when Myt1l expression is combined with the pro-myogenic factor Myod1, this latter unexpectedly promotes the emergence of neurons by binding promiscuously to neural genes.”
Quote in the paperSubstantial claim - Premisenone given§ Pioneer TF activity in regeneration and cancer initiation
In the skin, the pioneer transcription factors Klf5 and Sox9, normally expressed in a mutually exclusive manner, are expressed simultaneously during wound response.
“In the skin, the pioneer TFs Klf5 and Sox9, normally expressed in a mutually exclusive manner, are expressed simultaneously during wound response.”
Quote in the paperNot a substantial claim
- It may state two separate claims as one. 44
- Probably not a substantial claim. 25
It may state two separate claims as one.
Premisenone given§ GlossaryOSKM improved recovery from toxin-mediated pancreas and muscle injury and reduced scar tissue formation following cutaneous wounds.
“OSKM also improved recovery from toxin-mediated pancreas and muscle injury and also reduced scar tissue formation following cutaneous wounds.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisecitation§ Pluripotent reprogramming is a stepwise processReprogramming is a stepwise process marked by the emergence of cellular intermediate states, with progressive gain of cellular plasticity and loss of cellular identity followed by activation of the pluripotent network.
“Reprogramming is a stepwise process marked by the emergence of cellular intermediate states, presenting a progressive gain of cellular plasticity (see Glossary) and loss of cellular identity followed by the activation of the pluripotent network [5,6].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitation§ GlossarySenescence promotes in vivo reprogramming via paracrine secretion of a variety of molecules, including IL-6.
“Senescence also promotes in vivo reprogramming via the paracrine secretion of a variety of molecules, including IL-6 [21].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ GlossaryOSK expression in mouse retinal ganglion cells restored youthful DNA methylation and transcriptomic patterns and reversed vision loss in both a glaucoma model and aged mice.
“Additionally, OSK expression in mouse retinal ganglion cells was found to restore youthful DNA methylation/transcriptomic patterns and to reverse vision loss in both a model of glaucoma and aged mice [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
Premisenone given§ GlossaryAdult mammalian cardiomyocytes are poorly proliferative and have low regenerative capability.
“Adult mammalian cardiomyocytes (CMs) are poorly proliferative and have low regenerative capability.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitation§ GlossaryVarious epigenetic clocks were developed to estimate age based on the level of methylation of a restricted number of CpG sites in the genome.
“In line with this, various epigenetic clocks were developed to estimate age based on the level of methylation of a restricted number of CpG sites in the genome [24][25][26].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Reprogramming in vivo triggers rejuvenation and improves regenerationReprogramming to pluripotency and generation of iPSCs is achievable in vivo, indicating that the microenvironment is not sufficient to constrain OSKM action.
“Reprogramming to pluripotency and generation of iPSCs is achievable in vivo, indicating that the microenvironment is not sufficient to constrain OSKM action [3].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ GlossaryPartial and cyclic reprogramming with OSKM 2 days per week led to erasure of epigenetic signs of aging and amelioration of various aging hallmarks in pathological and normal aging.
“In addition, pioneer works revealed that a regimen of partial and cyclic reprogramming (mice were exposed to OSKM 2 days per week) led to the erasure of epigenetic signs of aging and to the amelioration of various aging hallmarks in the context of not only pathological, but also normal aging [9,11,28].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ GlossaryCyclic OSKM expression induces rejuvenation in the central nervous system and restored adult hippocampal neuron migration in the dentate gyrus of old mice, associated with partial improvement of cognitive functions.
“Cyclic OSKM expression also induces rejuvenation in the central nervous system.It restored adult hippocampal neuron migration in the dentate gyrus of old mice, associated with partial improvement of cognitive functions [30].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisenone given§ A tumorigenic risk is associated with in vivo reprogrammingAn acute effect of OSKM is formation of dysplastic lesions in multiple tissues, but dysplasia is often reversed following short exposure to OSKM of about 2 days.
“An acute effect of OSKM is the formation of dysplastic lesions in multiple tissues, but dysplasia is often reversed following short exposure to OSKM (~2 days).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisenone given§ GlossaryOSKM action is dependent on the developmental stage of cardiomyocytes; it can sustain an immature proliferative state in neonatal cardiomyocytes while allowing acquisition of a mitosis-competent state in adult cardiomyocytes.
“OSKM action is dependent on the developmental stage of CMs.It can sustain an immature proliferative state in neonatal CMs, while allowing the acquisition of a mitosis-competent state in adult CMs.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisecitation§ GlossaryRepeated induction of double-strand breaks led to erosion of the epigenetic landscape, partial loss of cellular identity, senescence, and advancement of the DNA methylation clock.
“However, the repeated induction of DSBs led to the erosion of the epigenetic landscape, partial loss of cellular identity, senescence, and advancement of DNA methylation clock [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationnone given§ GlossaryThe parameters of OSKM exposure, expression level and duration, required to achieve beneficial effects are cell type and/or organ specific.
“However, the parameters of OSKM exposure (expression level and duration) required to achieve beneficial effects are cell type and/or organ specific.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisecitation§ Reprogramming in vivo triggers rejuvenation and improves regenerationOSKM ubiquitous expression triggers formation of differentiated teratomas in various organs, revealing that multiple cell types are capable of reprogramming with different kinetics.
“In detail, OSKM ubiquitous expression triggers the formation of differentiated teratomas in various organs (pancreas, kidney, intestine, adipose tissue, liver, intracranial, stomach, and heart), revealing that multiple cell types are capable of reprogramming with different kinetics [3,10].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisenone given§ A tumorigenic risk is associated with in vivo reprogrammingThe full reprogramming process ultimately leads to formation of teratomas, but development of these benign tumors reflects acquisition of a multilineage differentiation potential.
“As mentioned previously, the full process ultimately leads to the formation of teratomas, but the development of these benign tumors simply reflects the acquisition of a multilineage differentiation potential.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisecitation§ Outstanding questionsPioneer TFs subsequently trigger nucleosome remodeling and induce different transcriptional programs to dictate embryonic lineage segregation and ensure lineage fidelity.
“Pioneer TFs subsequently trigger nucleosome remodeling and induce different transcriptional programs to dictate embryonic lineage segregation and ensure lineage fidelity[42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitation§ Outstanding questionsDuring normal development, developmental signals drive the expression of pioneer TFs by specific enhancers.
“During normal development, developmental signals drive the expression of pioneer TFs by specific enhancers.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisecitation§ Outstanding questionsLINE-1 expression is high in pre-implantation embryos, in which it regulates transcription and developmental potency.
“Meanwhile, LINE-1 expression is high in pre-implantation embryos, in which it regulates transcription and developmental potency [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Reprogramming generates cellular plasticityThe trajectories of reprogramming are dependent on the cell type of origin and on the cocktail of factors.
“Of note, the trajectories of reprogramming are dependent on the cell type of origin and on the cocktail of factors [37,38].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [38]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitation§ Outstanding questionsMyt1l converts the pro-myogenic factor Myod1 into a pro-neuronal factor by inhibiting the muscle program and exploiting Myod1 promiscuous binding to neuronal genes.
“Myt1l converts the pro-myogenic factor Myod1 into a pro-neuronal factor by inhibiting the muscle program and exploiting Myod1 promiscuous binding to neuronal genes [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Pioneer TF activity in regeneration and cancer initiationIn the lung, TP53 promotes lineage infidelity and its genetic inactivation stalls cells in a mixed state, indicating that loss of this tumor suppressor can be directly responsible for persistence of lineage infidelity.
“In the lung, TP53 promotes lineage infidelity and its genetic inactivation stalls the cells in this mixed state, indicating that the loss of this tumor suppressor can be directly responsible for the persistence of lineage infidelity [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Trends in Cell BiologyOSK expression in inducible changes to the epigenome fibroblasts restored age-associated mRNA changes and epigenetic age without impacting cellular identity.
“OSK expression in inducible changes to the epigenome (ICE) fibroblasts restored age-associated mRNA changes and epigenetic age without impacting cellular identity [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiationAscl1 and Myod1 are two pioneer basic helix-loop-helix transcription factors that are sequence related but drive transdifferentiation of mouse embryonic fibroblasts into neural and muscular cells, respectively.
“As another example, Ascl1 and Myod1 are two pioneer basic helix-loop-helix (bHLH) TFs that are sequence related but drive the transdifferentiation of MEFs into neural and muscular cells, respectively [17] (Figure 2B).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisereasoning§ Pioneer TF activity in regeneration and cancer initiationNumerous embryonic pioneer transcription factors are induced in adult lineages in response to stress and/or during cancer formation, highlighting how embryonic programs might have been co-opted during evolution as stress-response options.
“Numerous embryonic pioneer TFs are induced in adult lineages in response to stress and/or during cancer formation, highlighting how embryonic programs might have been co-opted during evolution as stress-response options (Table 1).”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper may give no reason why it holds.
Interpretationnone given§ Concluding remarksPioneer TF activity is directly related to their ability to reprogram, regenerate, and potentially poise the cells for oncogenic transformation.
“Pioneer TF activity is directly related to their ability to reprogram, regenerate, and potentially poise the cells for oncogenic transformation.”
Quote in the paperNot a substantial claimProbably not a substantial claim. It may state two separate claims as one.
Interpretationnone given§ Outstanding questionsDuring the early phase of reprogramming, the epigenetic marks are remodeled and cellular intermediates gain in cellular plasticity.
“During the early phase of reprogramming, the epigenetic marks are remodeled and cellular intermediates gain in cellular plasticity.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiationMyod1 binds promiscuously to neuronal genes and Ascl1 to myogenic ones.
“Moreover, and in line with the generation of cellular plasticity by pioneer TFs, the pro-myogenic factor Myod1 was found to bind promiscuously to neuronal genes and the pro-neuronal factor Ascl1 to myogenic ones [47].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Interpretationcitation§ Trends in Cell BiologyIf reprogramming is separated into three phases, initiation, maturation, and stabilization, rejuvenation could be pushed to the maturation phase, where the complete pluripotency program is attained.
“By contrast, work in human fibroblasts showed that, if reprogramming were to be separated in three phases (initiation, maturation, and stabilization), rejuvenation could be pushed to the maturation phase, where the complete pluripotency program is attained [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiationDistinct changes in fate specification were due to strong differences in DNA-binding affinity of Ascl1 and Myod1 and to their respective interaction with cofactors.
“These distinct changes in fate specification were found to be due to strong differences in the DNA-binding affinity of Ascl1 and Myod1 and to their respective interaction with cofactors.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitation§ Reprogramming generates cellular plasticityAberrant gene inductions initially reported in pioneer bulk RNA-sequencing analysis were considered to be disorganized gene expression.
“Interestingly, aberrant gene inductions were initially reported in pioneer bulk RNA-sequencing analysis but considered to be disorganized gene expression [39].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitation§ Outstanding questionsDepletion of LINE-1 RNA in dermal fibroblast cells from patients with different progeroid syndromes restores heterochromatin H3K9Me3/H3K27Me3 marks and reverses DNA methylation age in vitro.
“Depletion of LINE-1 RNA in dermal fibroblast cells from patients with different progeroid syndromes was recently found to restore heterochromatin H3K9Me3/H3K27Me3 marks and reverse DNA methylation age in vitro [68].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Uncoupling cellular identity, plasticity, and aging during reprogrammingFibroblast identity repression occurs by distinct mechanisms depending on the reprogramming factor used, Ascl1, MyoD1, FoxA2, Sox2, or Oct4, and no general principle emerged, highlighting that different entry points exist to erase cell identity.
“Fibroblast identity repression was found to occur by distinct mechanisms depending on the reprogramming factor used (Ascl1, MyoD1, FoxA2, Sox2, or Oct4) and no general principle emerged, highlighting that different entry points exist to erase cell identity [55].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiationNucleosomes impair DNA binding of transcription factors, but a specific class of embryonic pioneer transcription factors interact with and remodel the nucleosome to open silent chromatin.
“Nucleosomes impair DNA binding of TFs, but a specific class of embryonic 'pioneer' TFs interact with, and remodel, the nucleosome to open silent chromatin, as reviewed elsewhere [42].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationcitation§ Trends in Cell BiologyThe effect of OSKMLN on the epigenetic clock of human fibroblasts and endothelial cells occurs before epigenetic changes of cellular identity, indicating that rejuvenation may be achievable while preserving cellular identity.
“The effect of OSKMLN on the epigenetic clock of human fibroblasts and endothelial cells was also described to occur before the epigenetic changes of cellular identity, indicating that rejuvenation may be achievable while preserving cellular identity [8].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
Premisecitation§ Outstanding questionsThe termination of pluripotent reprogramming (cyclic or by pulse) in this time window contributes to rejuvenation and regeneration.
“The termination of pluripotent reprogramming (cyclic or by pulse) in this time window contributes to rejuvenation and regeneration[9,11].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ Uncoupling cellular identity, plasticity, and aging during reprogrammingA special relationship between the germ layer of the cell of origin and the transcription factor was evidenced, and the mesodermal factor Myod1 was found to repress fibroblast identity most potently.
“A special relationship between the germ layer of the cell of origin and the TF was evidenced, and the mesodermal factor Myod1 was found to repress fibroblast identity most potently.”
Quote in the paperSubstantial claimProbably not a substantial claim. It may state two separate claims as one.
Interpretationreasoning§ Outstanding questionsReprogramming can trigger not only rejuvenation but also cancer development.
“Reprogramming can trigger not only rejuvenation but also cancer development.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationnone given§ Outstanding questionsThe dosage of OSKM controls the final epigenetic landscape of reprogramming.
“The dosage of OSKM controls the final epigenetic landscape of reprogramming.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiationDuring early steps of reprogramming, OSK redistribute c-Myc on the mouse embryonic fibroblast genome, which may divert it from its tumorigenic action.
“During the early steps of reprogramming, OSK were found to redistribute c-Myc on the MEF genome, which may divert it from its tumorigenic action [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
Interpretationreasoning§ Outstanding questionsReprogramming triggers various outcomes, including rejuvenation, regeneration, and cancer.
“reprogramming triggers various outcomes, including rejuvenation, regeneration, and cancer.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisecitation§ Outstanding questionsNanog was reported to confer a youthful phenotype to senescent myoblasts and to improve molecular features of skeletal muscle in a mouse model of premature aging.
“Moreover, Nanog was also reported to confer a youthful phenotype to senescent myoblasts and to improve molecular features of skeletal muscle in a mouse model of premature aging [64].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationreasoning§ Outstanding questionsAfter the point of no return, the outcome of prolonged reprogramming and oncogenic transformation is engaged.
“After this point, the outcome of prolonged reprogramming and oncogenic transformation is engaged.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationnone given§ Outstanding questionsThe effects of reprogramming are due, at least partly, to epigenetic modifications that depend on OSKM level and duration of expression.
“These effects are due, at least partly, to epigenetic modifications that depend on OSKM level and duration of expression.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationreasoning§ Pioneer TF activity in regeneration and cancer initiationPioneer transcription factor activity influences both regeneration and tumorigenesis.
“These findings highlight how pioneer TF activity influences both regeneration and tumorigenesis.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisecitation§ A tumorigenic risk is associated with in vivo reprogrammingLow OSKM expression led to teratoma formation, whereas high levels triggered generation of malignant tumors.
“Low OSKM expression led to teratoma formation, whereas high levels triggered the generation of malignant tumors [33].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisenone given§ Pioneer TF activity in regeneration and cancer initiationDuring wound repair, activity of stress-responsive enhancers decreases and the Klf5/Sox9 balance is restored.
“However, during wound repair, the activity of those 'stress-responsive' enhancers decreases and the Klf5/Sox9 balance is restored.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationcitation§ Reprogramming generates cellular plasticityAlternative routes appear mainly absent from chemical-mediated reprogramming, indicating that use of pioneer transcription factors might be responsible for aberrant acquisition of cellular plasticity.
“Nonetheless, these alternative routes appear mainly absent from chemical-mediated reprogramming, indicating that the use of pioneer TFs (see next section) might be responsible for such aberrant acquisition of cellular plasticity [40].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationreasoning§ A tumorigenic risk is associated with in vivo reprogrammingDNA methylation changes were partial, indicating that abnormal growth of unsuccessfully reprogrammed cells can lead to tumor formation in which a hybrid epigenetic landscape has been stabilized.
“Similarly, DNA methylation changes were partial, indicating that the abnormal growth of unsuccessfully reprogrammed cells can lead to tumor formation in which a hybrid epigenetic landscape has been stabilized (Figure 1).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisecitation§ A tumorigenic risk is associated with in vivo reprogrammingShort OSKM exposure of 6 days led to moderate signs of reversible cardiac remodeling, while prolonged time of 21 days triggered development of epithelial-like neoplasms.
“Short OSKM exposure (6 days) led to moderate signs of reversible cardiac remodeling, while prolonged time (21 days) triggered the development of epithelial-like neoplasms.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
Interpretationnone given§ Concluding remarksSomatic cells acquire a hybrid unstable epigenetic landscape that is initially reversible.
“As depicted in Figure 1, we posit that somatic cells acquire a hybrid unstable epigenetic landscape that is initially reversible.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisecitation§ Outstanding questionsThe pioneer TFs OSK trigger widespread reconfiguration of chromatin and redistribute on the chromatin c-Myc and MEF cofactors, such as Runx1, Cebpa/b, and Fra1.
“The pioneer TFs OSK trigger widespread reconfiguration of chromatin and redistribute on the chromatin c-Myc and mouse embryonic fibroblast (MEF) cofactors, such as Runx1, Cebpa/b, and Fra1[18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisecitation§ A tumorigenic risk is associated with in vivo reprogrammingTumors in the pancreas harbor gene signatures related to germ cell tumors, in accordance with a rejuvenating role of OSKM.
“Tumors in the pancreas harbor gene signatures related to germ cell tumors, in accordance with a 'rejuvenating' role of OSKM [33].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationcitation§ Uncoupling cellular identity, plasticity, and aging during reprogrammingAn optimal, cell type-specific level of reprogramming factors exists, which is sufficient for reprogramming and may also minimize the risk of failure and/or tumorigenicity.
“It indicates that an optimal, cell type-specific level of reprogramming factors exists, which is sufficient for reprogramming and that may also minimize the risk of failure and/or tumorigenicity [33].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationreasoning§ Reprogramming generates cellular plasticityThe action of pioneer transcription factors is not exclusively deterministic toward a specific cell fate; pioneer transcription factors also generate cellular plasticity and windows of opportunity for somatic cells to engage into alternative paths.
“Collectively, these studies show that the action of pioneer TFs is not exclusively deterministic toward a specific cell fate.Pioneer TFs also generate cellular plasticity and windows of opportunity for somatic cells to engage into alternative paths.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisecitation§ Pioneer TF activity during reprogramming and transdifferentiationNeuroD1 during direct conversion of mouse microglia into neurons involves transcriptional repressors; NeuroD1 initially binds closed bivalent chromatin regions to induce neuronal gene expression, and among its primary targets, transcriptional repressors Scrt1 and Meis2 are induced to silence the microglial program.
“Furthermore, dissecting the action of the pioneer TF NeuroD1 during the direct conversion of mouse microglia into neurons also involves transcriptional repressors.NeuroD1 initially binds to closed bivalent chromatin regions to induce neuronal gene expression.Among NeurodD1 primary targets, the transcriptional repressors Scrt1 and Meis2 are induced to silence the microglial program [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Premisenone given§ Pioneer TF activity in regeneration and cancer initiationAcinar-to-ductal metaplasia facilitates pancreas regeneration and is resolved by redifferentiation.
“This transient process, termed acinar-to-ductal metaplasia (ADM), facilitates pancreas regeneration and is resolved by redifferentiation.”
Quote in the paperSubstantial claimProbably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
Premisecitation§ Outstanding questionsDuring tumorigenesis, activation of novel high stress enhancers by the oncogenic insult stabilizes lineage infidelity events.
“During tumorigenesis, activation of novel high stress enhancers by the oncogenic insult stabilizes lineage infidelity events[69].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
Premisecitation§ Outstanding questionsPioneer TF expression is transiently activated via stress and/or injury enhancers during regeneration, leading to mixed cellular identity.
“Pioneer TF expression is transiently activated via stress and/or injury enhancers during regeneration, leading to mixed cellular identity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisecitation§ Outstanding questionsThese transient lineage infidelity events contribute to repair and are rapidly resolved by redifferentiation.
“These transient lineage infidelity events contribute to repair and are rapidly resolved by redifferentiation[54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
Studies of reprogramming in vivo are not numerous and most findings still rely on in vitro work.
“First, the studies of reprogramming in vivo are not numerous and most findings still rely on in vitro work.”
The paper relies on this without support.
The partial restoration of a youthful gene expression pattern is limited and may not significantly correlate with the functional reversion of an aging phenotype.
“The partial restoration of a youthful gene expression pattern is limited and may not significantly correlate with the functional reversion of an aging phenotype.”
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017
Multipotent cell lineages in early mouse development depend on SOX2 functionPreprint
Avilion, A. A., Nicolis, S. K., Pevny, L., Pérez, L., Vivian, N., & Lovell-Badge, R. H. (2003) · Genes & Development · doi:10.1101/gad.224503 · Cited by 2,372
Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
Foster, J. W., Dominguez-Steglich, M., Guioli, S., Kwok, C., Weller, P., Stevanović, M., Weissenbach, J., Mansour, S., Young, I., Goodfellow, P., et al. (1994) · Nature · doi:10.1038/372525a0 · Cited by 1,602
Mu, P., Zhang, Z., Benelli, M., Karthaus, W. R., Hoover, E., Chen, C.-C., Wongvipat, J., Ku, S., Gao, D., Cao, Z., et al. (2017) · Science · doi:10.1126/science.aah4307 · Cited by 1,089
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988
Soufi, A., Donahue, G., & Zaret, K. S. (2012) · Cell · doi:10.1016/j.cell.2012.09.045 · Cited by 933
Schiebinger, G., Shu, J., Tabaka, M., Cleary, B., Subramanian, V., Solomon, A., Gould, J., Liu, S., Lin, S., Berube, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.006 · Cited by 829
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820
Horvath, S., Oshima, J., Martin, G. M., Lu, A. T., Quach, A., Cohen, H., Felton, S., Matsuyama, M., Lowe, D., Kabacik, S., et al. (2018) · Aging · doi:10.18632/aging.101508 · Cited by 815
Klf4 is a transcription factor required for establishing the barrier function of the skin
Segre, J. A., Bauer, C. R., & Fuchs, E. V. (1999) · Nature Genetics · doi:10.1038/11926 · Cited by 810
Mertens, J., Paquola, A. C. M., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., McGrath, S., Campbell, B., Lee, H., Herdy, J. R., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.001 · Cited by 765
A core Klf circuitry regulates self-renewal of embryonic stem cells
Jiang, J., Chan, Y.-S., Loh, Y., Cai, J., Tong, G., Lim, C.-A., Robson, P., Zhong, S., & Ng, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1698 · Cited by 746
Epigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697
Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., Cantor, A. B., & Orkin, S. H. (2010) · Cell · doi:10.1016/j.cell.2010.09.010 · Cited by 683
Loss of epigenetic information as a cause of mammalian aging
Yang, J.-H., Hayano, M., Griffin, P. T., Amorim, J. A., Bonkowski, M. S., Apostolides, J. K., Salfati, E. L., Blanchette, M., Munding, E. M., Bhakta, M., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.027 · Cited by 643
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589
A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity
Percharde, M., Lin, C.-J., Yin, Y., Guan, J., Peixoto, G. A., Bulut-Karslıoğlu, A., Biechele, S., Huang, B., Shen, X., & Ramalho‐Santos, M. (2018) · Cell · doi:10.1016/j.cell.2018.05.043 · Cited by 570
Kobayashi, Y., Tata, A., Konkimalla, A., Katsura, H., Lee, R. F., Ou, J., Banovich, N. E., Kropski, J. A., & Tata, P. R. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0542-8 · Cited by 559
Cooperative Binding of Transcription Factors Orchestrates Reprogramming
Chronis, C., Fiziev, P., Papp, B., Butz, S., Bonora, G., Sabri, S., Ernst, J., & Plath, K. (2017) · Cell · doi:10.1016/j.cell.2016.12.016 · Cited by 555
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. (2013) · Nature · doi:10.1038/nature12586 · Cited by 547
Deterministic direct reprogramming of somatic cells to pluripotency
Rais, Y., Zviran, A., Geula, S., Gafni, O., Chomsky, E., Viukov, S., Mansour, A. A., Caspi, I., Krupalnik, V., Zerbib, M., et al. (2013) · Nature · doi:10.1038/nature12587 · Cited by 522
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460
The transcription factor GATA6 is essential for early extraembryonic development
Koutsourakis, M., Langeveld, A., Patient, R. K., Beddington, R. S. P., & Grosveld, F. G. (1999) · Development · doi:10.1242/dev.126.4.723 · Cited by 454
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
Marjanovic, N. D., Hofree, M., Chan, J. E., Canner, D. A., Wu, K., Trakala, M., Hartmann, G. G., Smith, O. C. G., Kim, J. Y., Evans, K. V., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.012 · Cited by 396
Chemical reprogramming of human somatic cells to pluripotent stem cells.
Guan, J., Wang, G., Wang, J., Zhang, Z., Fu, Y., Cheng, L., Meng, G., Lyu, Y., Zhu, J., Li, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04593-5 · Cited by 388
SOX9 induces and maintains neural stem cells
Scott, C. E., Wynn, S. L., Sesay, A. K., Cruz, C., Cheung, M. C. H., Gómez‐Gaviro, M. V., Booth, S., Gao, B., Cheah, K. S. E., Lovell-Badge, R. H., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2646 · Cited by 356
Caloric Restriction Reprograms the Single-Cell Transcriptional Landscape of Rattus Norvegicus Aging
Ma, S., Sun, S., Geng, L., Song, M., Wang, W., Ye, Y., Ji, Q., Zou, Z., Wang, S., He, X., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.008 · Cited by 349
Stem Cell Lineage Infidelity Drives Wound Repair and Cancer
Ge, Y., Gomez, N. C., Adam, R. C., Nikolova, M., Yang, H., Verma, A., Lu, C. P.-J., Polak, L., Yuan, S., Elemento, O., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.042 · Cited by 341
Pioneer transcription factors, chromatin dynamics, and cell fate control
Zaret, K. S., & Mango, S. E. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.12.003 · Cited by 337
Sarkar, T. J., Quarta, M., Mukherjee, S., Colville, A., Paine, P., Doan, L., Tran, C. M., Chu, C. R., Horvath, S., Qi, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15174-3 · Cited by 308
Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice
Chen, Y., Lüttmann, F. F., Schoger, E., Schöler, H. R., Zelarayán, L. C., Kim, K.-P., Haigh, J. J., Kim, J., & Braun, T. (2021) · Science · doi:10.1126/science.abg5159 · Cited by 297
A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration
Zhang, Y., Goss, A., Cohen, E. D., Kadzik, R. S., Lepore, J. J., Muthukumaraswamy, K., Yang, J., DeMayo, F. J., Whitsett, J. A., Parmacek, M. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.157 · Cited by 284
Mertens, J., Reid, D. A., Lau, S., Kim, Y., & Gage, F. H. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031534 · Cited by 263
Browder, K. C., Reddy, P., Yamamoto, M., Haghani, A., Guillen, I. G., Sahu, S., Wang, C., Luque, Y., Prieto, J., Shi, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00183-2 · Cited by 253
Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients
Mertens, J., Herdy, J. R., Traxler, L., Schafer, S. T., Schlachetzki, J. C. M., Böhnke, L., Reid, D. A., Lee, H., Zangwill, D., Fernandes, D. P., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.004 · Cited by 240
Kumar, S., Liu, J., Pang, P. D., Krautzberger, A. M., Reginensi, A., Akiyama, H., Schedl, A., Humphreys, B. D., & McMahon, A. P. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.034 · Cited by 232
Matsuda, T., Irie, T., Katsurabayashi, S., Hayashi, Y., Nagai, T., Hamazaki, N., Adefuin, A. M. D., Miura, F., Ito, T., Kimurâ, H., et al. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.010 · Cited by 231
Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates
Mall, M., Kareta, M. S., Chanda, S., Ahlenius, H., Perotti, N., Zhou, B., Grieder, S. D., Ge, X., Drake, S., Euong Ang, C., et al. (2017) · Nature · doi:10.1038/nature21722 · Cited by 225
Reprogramming roadmap reveals route to human induced trophoblast stem cells
Liu, X., Ouyang, J. F., Rossello, F. J., Tan, J. P., Davidson, K. C., Valdes, D. S., Schröder, J., Sun, Y., Chen, J., Knaupp, A. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2734-6 · Cited by 202
Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency
Studer, L., Vera, E., & Cornacchia, D. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.05.004 · Cited by 191
Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity
Olova, N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2019) · Aging Cell · doi:10.1111/acel.12877 · Cited by 190
Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
Gill, D., Parry, A., Santos, F., Okkenhaug, H., Todd, C. D., Hernando-Herraez, I., Stubbs, T. M., Milagre, I., & Reik, W. (2022) · eLife · doi:10.7554/elife.71624 · Cited by 185
Winkler, M., Staniczek, T., Kürschner, S. W., Schmid, C. D., Schönhaber, H., Cordero, J., Kessler, L., Mathes, A., Sticht, C., Neßling, M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.033 · Cited by 184
Senescence promotes in vivo reprogramming through p16INK4a and IL‐6
Mosteiro, L., Pantoja, C., de Martino, A., & Serrano, M. (2018) · Aging Cell · doi:10.1111/acel.12711 · Cited by 182
Inhibition of Transcription Factor GATA-4 Expression Blocks In Vitro Cardiac Muscle Differentiation
Grépin, C., Robitaille, L., Antakly, T., & Nemer, M. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4095 · Cited by 179
Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties
Donati, G., Rognoni, E., Hiratsuka, T., Liakath‐Ali, K., Hoste, E., Kar, G., Kayikci, M., Russell, R., Kretzschmar, K., Mulder, K. W., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3532 · Cited by 176
Plasticity and Dedifferentiation within the Pancreas: Development, Homeostasis, and Disease
Puri, S., Folias, A. E., & Hebrok, M. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.11.001 · Cited by 172
Chia, N., Deng, N., Das, K., Huang, D., Hu, L., Zhu, Y., Lim, K. H., Lee, M., Wu, J., Sam, X. X., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306596 · Cited by 171
Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
Ge, Y., & Fuchs, E. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.9 · Cited by 169
Wei, D., Wang, L., Yan, Y., Jia, Z., Gagea, M., Li, Z., Zuo, X., Kong, X., Huang, S., & Xie, K. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.005 · Cited by 156
Single-Cell RNA-Seq Reveals Dynamic Early Embryonic-like Programs during Chemical Reprogramming
Zhao, T., Fu, Y., Zhu, J., Liu, Y., Zhang, Q., Yi, Z., Chen, S., Jiao, Z., Xu, X., Xu, J., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.05.025 · Cited by 153
High-resolution analysis with novel cell-surface markers identifies routes to iPS cells
O’Malley, A. J., Skylaki, S., Iwabuchi, K. A., Chantzoura, E., Ruetz, T. J., Johnsson, A., Tomlinson, S. R., Linnarsson, S., & Kaji, K. (2013) · Nature · doi:10.1038/nature12243 · Cited by 150
The oncogene c-Jun impedes somatic cell reprogramming
Liu, J., Han, Q., Peng, T., Peng, M., Wei, B., Li, D., Wang, X., Yu, S., Yang, J., Cao, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3193 · Cited by 146
Pioneer and nonpioneer factor cooperation drives lineage specific chromatin opening
Mayran, A., Sochodolsky, K., Khetchoumian, K., Harris, J., Gauthier, Y., Bemmo, A., Balsalobre, A., & Drouin, J. (2019) · Nature Communications · doi:10.1038/s41467-019-11791-9 · Cited by 141
Huang, J., Wei, F.-K., Xu, X., Ye, S.-X., Song, J., Ding, P., Zhu, J., Li, H.-F., Luo, X., Gong, H., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1895-2 · Cited by 137
Salivary glands regenerate after radiation injury through SOX2‐mediated secretory cell replacement
Emmerson, E., May, A. J., Berthoin, L., Cruz‐Pacheco, N., Nathan, S., Mattingly, A. J., Chang, J. L., Ryan, W. R., Tward, A. D., & Knox, S. M. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708051 · Cited by 135
Mardaryev, A. N., Meier, N. T., Poterlowicz, K., Sharov, A. A., Sharova, T. Y., Ahmed, M. I., Rapisarda, V., Lewis, C. J., Fessing, M. Y., Rünger, T. M., et al. (2011) · Development · doi:10.1242/dev.070284 · Cited by 132
Whissell, G., Montagni, E., Martinelli, P., Hernando‐Momblona, X., Sevillano, M., Jung, P., Cortina, C., Calon, A., Abulí, A., Castells, A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2992 · Cited by 129
Della Valle, F., Reddy, P., Yamamoto, M., Liu, P., Saera-Vila, A., Bensaddek, D., Zhang, H., Prieto Martinez, J., Abassi, L., Celii, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6057 · Cited by 127
Knaupp, A. S., Buckberry, S., Pflueger, J., Lim, S. M., Ford, E., Larcombe, M. R., Rossello, F. J., de Mendoza, A., Alaei, S., Firas, J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.007 · Cited by 127
Wang, C., Rabadan Ros, R., Martinez-Redondo, P., Ma, Z., Shi, L., Xue, Y., Guillen-Guillen, I., Huang, L., Hishida, T., Liao, H.-K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23353-z · Cited by 119
A Sox9/Fgf feed-forward loop maintains pancreatic organ identity
Seymour, P. A., Shih, H.-P., Patel, N. A., Freude, K., Xie, R., Lim, C. J., & Sander, M. (2012) · Development · doi:10.1242/dev.078733 · Cited by 117
In Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice.
Rodríguez-Matellán, A., Alcazar, N., Hernández, F., Serrano, M., & Ávila, J. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.09.010 · Cited by 116
In vivo partial cellular reprogramming enhances liver plasticity and regeneration
Hishida, T., Yamamoto, M., Hishida-Nozaki, Y., Shao, C., Huang, L., Wang, C., Shojima, K., Xue, Y., Hang, Y., Shokhirev, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110730 · Cited by 116
Cellular Pliancy and the Multistep Process of Tumorigenesis
Puisieux, A., Pommier, R. M., Morel, A., & Lavial, F. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.007 · Cited by 114
Self-citationThe transcription factor GATA6 is essential for early extraembryonic development
Koutsourakis, M., Langeveld, A., Patient, R. K., et al. (1999) · Development · doi:10.1242/dev.126.9.723 · Cited by 114
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
Jeselsohn, R. M., Cornwell, M., Pun, M. J., Buchwalter, G., Nguyen, M., Bango, C., Huang, Y., Kuang, Y., Paweletz, C. P., Fu, X., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620993114 · Cited by 112
Resolving Cell Fate Decisions During Somatic Cell Reprogramming by Single-Cell RNA-Seq
Guo, L., Lin, L., Wang, X., Gao, M., Cao, S., Mai, Y., Wu, F., Kuang, J., Liu, H., Yang, J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2019.01.042 · Cited by 112
GATA4 regulates Fgf16 to promote heart repair after injury
Yu, W., Huang, X., Tian, X., Zhang, H., He, L., Wang, Y., Nie, Y., Hu, S., Lin, Z., Zhou, B., et al. (2016) · Development · doi:10.1242/dev.130971 · Cited by 109
Sox2-Mediated Regulation of Adult Neural Crest Precursors and Skin Repair
Johnston, A. P. W., Naska, S., Jones, K., Jinno, H., Kaplan, D. R., & Miller, F. D. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.04.004 · Cited by 96
Klf5 regulates lineage formation in the pre-implantation mouse embryo
Lin, S. J., Wani, M. A., Whitsett, J. A., & Wells, J. M. (2010) · Development · doi:10.1242/dev.054775 · Cited by 94
Lin, L., Bass, A. J., Lockwood, W. W., Wang, Z., Silvers, A. L., Thomas, D. G., Chang, A. C., Lin, J., Orringer, M. B., Li, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011989109 · Cited by 84
Zhao, C., Ma, D., Zawadzka, M., Fancy, S. P. J., Elis-Williams, L., Bouvier, G., Stockley, J. H., de Castro, G. M., Wang, B., Jacobs, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3655-14.2015 · Cited by 83
Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo
Doeser, M. C., Schöler, H. R., & Wu, G. (2018) · Stem Cells · doi:10.1002/stem.2842 · Cited by 83
Roux, A. E., Zhang, C., Paw, J., Zavala-Solorio, J., Malahias, E., Vijay, T., Kolumam, G., Kenyon, C., & Kimmel, J. C. (2022) · Cell Systems · doi:10.1016/j.cels.2022.05.002 · Cited by 78
In vivo reprogramming drives Kras-induced cancer development
Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04449-5 · Cited by 76
Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity
Lin, S., Chou, Y., Jiang, S. S., Chang, J.-L., Chung, C.-H., Kao, Y.-R., Chang, I., & Wu, C.-W. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3178 · Cited by 73
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance
Ozmadenci, D., Féraud, O., Markossian, S., Kress, E., Ducarouge, B., Gibert, B., Ge, J., Durand, I., Gadot, N., Plateroti, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8398 · Cited by 70
Self-citationThe transcription factor GATA4 is required for follicular development and normal ovarian function
Efimenko, E., Padua, M. B., Manuylov, N. L., Fox, S. C., Morse, D. A., & Tevosian, S. G. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.06.004 · Cited by 68
Zviran, A., Mor, N., Rais, Y., Gingold, H., Peles, S., Chomsky, E., Viukov, S. V., Buenrostro, J. D., Scognamiglio, R., Weinberger, L., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.11.014 · Cited by 68
Alle, Q., Le Borgne, E., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F., Bertrand‐Gaday, C., Pessemesse, L., Toupet, K., et al. (2022) · Aging Cell · doi:10.1111/acel.13714 · Cited by 66
Wang, B., Wu, L., Li, D., Liu, Y., Guo, J., Li, C., Yao, Y., Wang, Y., Zhao, G., Wang, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.068 · Cited by 64
Cell Type of Origin Dictates the Route to Pluripotency
Nefzger, C. M., Rossello, F. J., Chen, J., Liu, X., Knaupp, A. S., Firas, J., Paynter, J. M., Pflueger, J., Buckberry, S., Lim, S. M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.029 · Cited by 53
Pro-neuronal activity of Myod1 due to promiscuous binding to neuronal genes
Lee, Q. Y., Mall, M., Chanda, S., Zhou, B., Sharma, K. S., Schaukowitch, K., Adrian-Segarra, J. M., Grieder, S. D., Kareta, M. S., Wapinski, O. L., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0490-3 · Cited by 50
Taguchi, J., Shibata, H., Kabata, M., Kato, M., Fukuda, K., Tanaka, A., Ohta, S., Ukai, T., Mitsunaga, K., Yamada, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25249-4 · Cited by 46
Gata6 promotes hair follicle progenitor cell renewal by genome maintenance during proliferation
Wang, A. B., Zhang, Y. V., & Tumbar, T. (2016) · The EMBO Journal · doi:10.15252/embj.201694572 · Cited by 40
Shahini, A., Rajabian, N., Choudhury, D., Shahini, S., Vydiam, K., Nguyen, T., Kulczyk, J., Santarelli, T., Ikhapoh, I., Zhang, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe5671 · Cited by 38
Zhang, X., Wu, S., Naccarato, T., Prakash-Damani, M., Chou, Y. K., Chu, C., & Zhu, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180138 · Cited by 37
Huyghe, A., Furlan, G., Schröder, J., Bachelard-Cascales, É., Trajkova, A., Ruel, M., Stüder, F., Larcombe, M. R., Sun, Y., Mugnier, F., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00986-w · Cited by 36
Self-citationKwon, O., Zhang, L., Jia, D., & Xin, L. (2020) · Oncogene · doi:10.1038/s41388-020-01526-2 · Cited by 35
Deciphering the roadmap of in vivo reprogramming toward pluripotency
Chondronasiou, D., Martínez de Villarreal, J., Melendez, E., Lynch, C. J., Pozo, N. D., Kovatcheva, M., Aguilera, M., Prats, N., Real, F. X., & Serrano, M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.09.009 · Cited by 34
Li, Y., Li, J., Hou, Z., Yu, Y. W., & Yu, B. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.100 · Cited by 31
Rogerson, C., Ogden, S., Britton, E., Ang, Y. S., & Sharrocks, A. D. (2020) · eLife · doi:10.7554/elife.57189 · Cited by 26
Natural killer cells act as an extrinsic barrier for in vivo reprogramming
Melendez, E., Chondronasiou, D., Mosteiro, L., de Villarreal, J. M., Fernández‐Alfara, M., Lynch, C. J., Grimm, D., Real, F. X., Alcamı́, J., Climent, N., et al. (2022) · Development · doi:10.1242/dev.200361 · Cited by 26
Probing cell identity hierarchies by fate titration and collision during direct reprogramming
Hersbach, B. A., Fischer, D. S., Masserdotti, G., Deeksha, Mojžišová, K., Waltzhöni, T., Rodriguez‐Terrones, D., Heinig, M., Theis, F. J., Götz, M., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211129 · Cited by 26
Okada, H., Yamada, M., Kamimoto, K., Kok, C., Kaneko, K., Ema, M., Miyajima, A., & Itoh, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002372 · Cited by 24
Turning back time with epigenetic clocks
Drew, L. (2022) · Nature · doi:10.1038/d41586-022-00077-8 · Cited by 22
MYC-Induced Epigenetic Activation of GATA4 in Lung Adenocarcinoma
Castro, I. C., Breiling, A., Luetkenhaus, K., Ceteci, F., Hausmann, S., Kreß, S., Lyko, F., Rudel, T., & Rapp, U. R. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0414-t · Cited by 20
Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6
Estape, A. A., Cai, W. L., Albert, A. E., Zhao, M., Stevens, L. E., López‐Giráldez, F., Patel, K. D., Tyagi, S., Schmitt, E. M., Westbrook, T. F., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1246-z · Cited by 19
Klf5 suppresses ERK signaling in mouse pluripotent stem cells
Azami, T., Matsumoto, K., Jeon, H., Waku, T., Muratani, M., Niwa, H., Takahashi, S., & Ema, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207321 · Cited by 18
Molecular versatility during pluripotency progression
Furlan, G., Huyghe, A., Combémorel, N., & Lavial, F. (2023) · Nature Communications · doi:10.1038/s41467-022-35775-4 · Cited by 18
Self-citationSoini, T., Eloranta, K., Pihlajoki, M., Kyrönlahti, A., Akinrinade, O., Andersson, N., Lohi, J., Pakarinen, M. P., Wilson, D. B., & Heikinheimo, M. (2018) · Tumor Biology · doi:10.1177/1010428318785498 · Cited by 17
Flagged first, then by citations
1 of the 108 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
Gulati, G. S., D'Silva, J. P., Liu, Y., Wang, L., & Newman, A. M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00768-2 · Cited by 335
Epigenomic heterogeneity as a source of tumour evolution
Laisné, M., Lupien, M., & Vallot, C. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00757-9 · Cited by 93
CEBPA restricts alveolar type 2 cell plasticity during development and injury-repair
Hassan, D., & Chen, J. (2024) · Nature Communications · doi:10.1038/s41467-024-48632-3 · Cited by 34
Genetic and epigenetic alterations in aging and rejuvenation of human
Park, K., Jeon, M. C., Lee, D., Kim, J., & Im, S.-W. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100137 · Cited by 29
The evolution of cancer and ageing: a history of constraint
de Magalhães, J. P. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00861-4 · Cited by 21
Ding, F., Yu, Y., Zhao, J., Wei, S., Zhang, Y., Han, J. H., Li, Z., Jiang, H., Ryu, D., Cho, M., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1593096 · Cited by 17
Targeting oncogene-induced cellular plasticity for tumor therapy
Li, B., Zheng, L., Yang, J., & Qu, L. (2024) · Advanced Biotechnology · doi:10.1007/s44307-024-00030-y · Cited by 13
Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis
Lin, H., Wang, X., Chung, M., Cai, S., & Pan, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06060-3 · Cited by 13
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications
Chen, W., & Wang, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03408-x · Cited by 13
Unlocking regeneration: how partial reprogramming resembles tissue healing
Adams, M. T., Jasper, H., & Mosteiro, L. (2025) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2025.102351 · Cited by 9
Cellular senescence as a therapeutic target for aging intervention
Bi, Y., & Ji, G. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100948 · Cited by 9
Overcoming muscle stem cell aging
Memczak, S., & Belmonte, J. C. I. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102127 · Cited by 8
Tumor Cell Plasticity in Cancer: Signaling Pathways and Pharmaceutical Interventions
Sun, S., Sun, Y., Lan, L., Luan, S., Zhou, J. R., Deng, J., Yuan, Y., & Wu, Z. (2025) · MedComm · doi:10.1002/mco2.70541 · Cited by 7
Park, C. S., Bridges, C. S., Lewis, A. H., Chen, T. J., Shai, S., Du, W., Puppi, M., Zorman, B., Pavel, S., & Lacorazza, H. D. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104730 · Cited by 5
Wang, C., Wang, Y., Gu, Y., Zhu, Y., Yin, R., Yang, L., & Gui, J. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314241311073 · Cited by 5
Emerging paradigms in cancer cell plasticity
Huh, H. D., & Park, H. W. (2024) · BMB Reports · doi:10.5483/bmbrep.2024-0018 · Cited by 5
Rethinking medical education through systems biology to address complexity
David, L., Gourraud, P., Lamirault, G., & Lemarchand, P. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00636-5 · Cited by 4
Induced Pluripotent Stem Cells Facilitate the Development and Evaluation of Cancer Vaccines
Zhai, Y., Xu, X., Fang, J., He, F., & Li, S. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0642 · Cited by 4
Merzlikin, N., Gerunov, T. V., Герунова, Л. К., Chigrinski, E. A., Tian, H., Gao, J., & Hua, J. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103059 · Cited by 3
Bacterial Ribosomes Induce Plasticity in Mouse Adult Fibroblasts
Datta, A., Istiaq, A., Tamura, S., & Ohta, K. (2024) · Cells · doi:10.3390/cells13131116 · Cited by 3
Implications of noncoding regulatory functions in the development of insulinomas
Ramos-Rodríguez, M., Subirana-Granés, M., Norris, R., Sordi, V., Fernández, Á., Fuentes-Páez, G., Pérez-González, B., Balaguer, C. B., Raurell‐Vila, H., Chowdhury, M., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100604 · Cited by 3
Microtubule Reorganization and Quiescence: an Intertwined Relationship
Laporte, D., & Sagot, I. (2024) · Physiology · doi:10.1152/physiol.00036.2024 · Cited by 3
An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers
Klagkou, E., Valakos, D., Foutadakis, S., Polyzos, A., Papadopoulou, A., Vatsellas, G., & Thanos, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313128 · Cited by 2
A small-molecule compound cocktail for tumor reprogramming therapy for breast cancer
Wang, Z., Huang, R., Kong, J., Wang, M., Yang, H., Yan, H., Chen, H. H., Han, Y. Y., & Li, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115273 · Cited by 2
Editorial: Catch me if you can: cellular plasticity in tumor progression and drug resistance
Vinciguerra, G. L. R., Segatto, I., Carstens, J. L., & Lovisa, S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1470518 · Cited by 2
Marensi, V., Oliveira, P. F., & Zamoner, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1580686 · Cited by 2
Dey, U., Martinez, G. S., Kumar, R., Yella, V. R., & Kumar, A. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.21.655105 · Cited by 2
Curylova, L., Zambo, I. S., Neradil, J., Kýr, M., Jurackova, N., Pavlová, Š., Polášková, K., Múdrý, P., Štěrba, J., Veselská, R., et al. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01020-x · Cited by 1
scNucMap: mapping the nucleosome landscapes at single-cell resolution
Xiang, Q., & Lai, B. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf324 · Cited by 1
SOX9 as a key regulator of tissue remodelling and epithelial cell fate transitions
Béjar, M. T., & Alcolea, M. P. (2026) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2026.102477 · Cited by 1
Shi, Y., Song, K., Zhou, W., Dong, Y., Song, W., Ran, R., 赵光海, Zhou, K., Wei, N., & Haihong, Z. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.152 · Cited by 1
Ismail, A. M., Saha, A., Morrissey, K. A., LUNDQUIST, D. K., Garcia, E., Balne, P. K., Cannon, J. L., Chodosh, J., & Rajaiya, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.23.650321 · Cited by 1
Li, C., Ren, S., Yan, C., Wang, C., Jiang, T., Kang, Y., Chen, J., Xiong, H., Guo, J., Jiang, G., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04002-w
A multi-step completion process model of cell plasticity
Chen, 陳. M.-J., & Yu, R. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf165
Clonal effects of the Ras oncogene revealed by somatic mutagenesis in a Drosophila cancer modelPreprint
Akiyama, T., & Gibson, M. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.08.652841
A Machine‐Learning Approach Identifies Rejuvenating Interventions in the Human Brain
Santamaria, G., Iglesias, C., Jung, S., Hodar, J. A., Nogueiras, R., & del Sol, A. (2025) · Advanced Science · doi:10.1002/advs.202503344
Lavial, F., Lopes, M., & Pereira, C. (2025) · Cellular Reprogramming · doi:10.1177/21524971251378893
Self-citationIntegrative Spatial Modelling of Cellular Plasticity using Graph Neural Networks and GeostatisticsPreprint
Withnell, E., Celik, C., & Secrier, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678189
Dhodapkar, M. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00513-5
Pioneer Transcription Factors Differentially Co-opt Bcl11a and Bcl11b to orchestrate ReprogrammingPreprint
Trajkova, A., Zakiev, E., Mendoza-Ferri, M. G., Messahli, I., Ruel, M., Krossa, I., Tapponnier, Y., Dejonckere, E., Hunter, E., Claret, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.694617
Self-citationPartial Reprogramming Is Conserved from Insect to Mammal
Tolwinski, N. S., Fong, S., Shankar, S., & Gruber, J. (2026) · Cells · doi:10.3390/cells15020168
Advancements in Blood-Derived Regenerative Therapies for Facial Rejuvenation
Nazari, A., & Casabona, G. R. (2026) · Springer eBooks · doi:10.1007/978-3-031-36962-9_332-1
Etude des régulateurs et des voies moléculaires impliqués dans les conversions d'état cellulaire
Trajkova, A. (2024) · theses.fr (ABES) · doi:10.70675/87dd8564zbfd1z4a6ezbc15z8a3402efe338
Self-citationMechanisms of Cell Plasticity during Injury-Induced Epithelial Reprogramming
Mazzarelli, E., & Lovisa, S. (2026) · Cells Tissues Organs · doi:10.1159/000552260
Li, M., Deng, H., Xu, H., Zhou, Q., & Zhao, S. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1842955
KDM8 acts as a co-regulator of transcription factor SOX2 for promoting cell pluripotency
Yang, S., Ye, Z., Lin, L., Jiang, Z., Wang, E., & Wang, J. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102963
Bhartiya, D., Sharma, N. S., Tripathi, A., & Tripathi, A. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11197-3
Role of epigenetic factors during blockade of the renin-angiotensin system across aging
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00417.2026
Repair and regeneration across the lifespan: an ontogenetic perspective
Barrera-saldaña, H. A., Fernández-Garza, L. E., Guillen-Silva, F., Fajardo‐Ramírez, Ó. R., Pavlovich, R. I., Gómez-Gallardo, F. V., Rodríguez-Fuentes, D. E., Avila-Villalobos, A. Y., Barrera‐Barrera, S. A., & Somoza, R. A. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1888854
Liu, X., Zhu, M., Zou, C., Cao, Z., Wang, Y., Yang, G., Liu, X., Wu, Y., Yu, D., Zheng, D., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103018
Muthu, S., & Lakshmikanthan, M. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100869
Ji, Z., Yu, Y., Cao, Q., Luo, D., Xu, H., Xu, H., Zhou, Y., Ma, M., Wang, G., Yin, Z., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181742
Singh, R. D., Calvoli, M., & Kim, K. K. (2026) · Advanced Science · doi:10.1002/advs.77370
Wei, N., Bhat, Z. I., Tang, Q., Huang, Y., Wong, Y. H., & Tan, J. L. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101616
Cell Reprogramming: Therapeutic Advances and Challenges
Li, A., Zhipeng, W., Lyu, Z., Tuo, Z., Li, X., Wu, R., Wang, J., Wusiman, D., Wang, Y., Zhang, Q., et al. (2026) · Research · doi:10.34133/research.1472
Single-cell chromatin accessibility atlas decodes bone development, diseases, and regeneration
Jin, Y., Wu, O., Hu, D., Zhou, H., Chen, D., 陈临节, You, X., Chen, Q., Kwan, K. Y. H., Makvandi, P., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.10.040
Metadata
- Authors
- Huyghe, A., Trajkova, A., & Lavial, F.
- Affiliations
- Lyon 1 Université (FR)
- Corresponding author
- Lavial, Fabrice
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 34
- Issue
- 3
- Pages
- 255-267
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W4386226359
- Cited by
- 56
- References
- 108
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 15
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Trends in Cell Biology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0061)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Institut National Du Cancer
- Fondation Bettencourt Schueller
- Centre Léon Bérard
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- cellular plasticity, in vivo reprogramming, OSKM transcription factors, rejuvenation, tissue regeneration, carcinogenesis, tumor initiation, aging, cell identity, pioneer transcription factors
- MeSH terms
- Cell Plasticity, Cell Transformation, Neoplastic, Humans, Rejuvenation, Transcription Factors, Octamer Transcription Factor-3, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells, Carcinogenesis, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review